Cancer Survivorship

“An individual is considered a cancer survivor from the time of diagnosis, through the balance of his or her life. Family members, friends, and caregivers are also impacted by the survivorship experience”.

Adapted from the National Coalition for Cancer Survivorship

Who Are We?

The Queensland Collaborative for Cancer Survivorship (QCCS) leads world-class research to improve patient outcomes from the time of diagnosis, and for the remainder of their life. Our collaborative comprises research leaders of international repute from the Queensland University of Technology, University of Queensland, QIMR Berghofer Medical Research Institute, Mater Misericordiae Ltd., Metro North Hospital and Health Service, Metro South Health, and Children’s Health Queensland. As cancer treatment continues to advance, there are now over 1 million cancer survivors living in Australia. These survivors suffer short- and long- term late effects (comorbidities and symptoms) from their cancer and its treatment. The Collaborative focuses on developing and evaluating health innovations that (1) promote best outcomes for patients; and (2) ensure high-quality, sustainable health services.

Partner Organisations

  • Queensland University of Technology
  • University of Queensland
  • QIMR Berghofer Medical Research Institute
  • Mater Misericordiae Ltd.
  • Metro North Hospital and Health Service
  • Metro South Health
  • Children’s Health Queensland


  1. Set common goals and deliverables for the collaborative;
  2. Enhance cross-disciplinary research and research translation to achieve better patient and system outcomes;
  3. Develop a strategic approach to lobby and apply for funding to support research activities;
  4. Seek clinical and administrative buy-in to implement best survivorship care and sustainable models of care across diverse clinical contexts including for patients living in regional, rural and remote areas;
  5. Involve and collaborate with clinicians in developing research ideas/proposals and dissemination/knowledge translation plans;
  6. Maintain a website including a register of research and research translation activities and work to enhance the visibility of the work conducted by the collaborative and their partners; and
  7. Form collaborative networks with relevant state and national cancer organisations professional bodies, and other centres of excellence in cancer survivorship.

Want to know more? 

Click here for the QCCS RESEARCH AGENDA 2020-2025

Contact Email